- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02146092
Incentive Spirometry Added to Physiotherapy to Reduce Postoperative Pulmonary Complications After Lung Surgery
Incentive Spirometry Added to Physiotherapy to Reduce Postoperative Pulmonary Complications After Lung Surgery: A Prospective Blinded Randomized Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
Ontario
-
Hamilton, Ontario, Canada, L8N 4A6
- St. Joseph's Healthcare Hamilton
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients must be at minimum age 18
- Patient must be undergoing pulmonary resection surgery for malignant or benign disease
- Patients must be able to understand English
- Patients must be able to demonstrate aptitude and willingness to comply with describes study procedures
Exclusion Criteria:
- Patients who are unable to read and communicate in English
- Home oxygen usage prior to operation
- Previous pulmonary resection or any thoracic surgery
- Radiological evidence of atelectasis or pneumonitis on preoperative imaging
- Radiological evidence of pleural effusion prior on preoperative imaging
- Prior exposure to pulmonotoxic drugs such as amiodarone or belomycin
- Current drug or alcohol use or dependence that, in the opinion of the site investigator, would interfere with adherence to study requirements.
- Inability or unwillingness of individual or legal guardian/representative to give written informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Standard physiotherapy
Standard physiotherapy includes routine physiotherapy care as per current institutional standards.
This consists of two daily visits by the physiotherapist.
During the visits, the patient will be taught deep breathing and will be instructed to practice it 10 times every hour.
They are also shown shoulder movements and lung expansion exercises.
They will receive a sheet summarizing the exercises for future reference.
The patient is discharged from physiotherapy when they are ambulatory, on room air, and able to clear their respiratory secretions independently, although they will be asked to continue the exercises on their own until 30 days from surgery.
|
Standard of care exercise training and supervision
|
Experimental: Incentive Spirometry
Patients in the Incentive Spirometry arm will receive standard physiotherapy care in addition to training and use of an incentive spirometer. The physiotherapy care includes routine care as per current institutional standards. They will also receive an incentive spirometer on the first postoperative day and will be taught how to use it with an accompanying instructional sheet for later reference. Teaching will emphasize slow deep breathing, sustained vacuum pressure, and gradual increase in difficulty. Patients will be instructed to use the spirometer 10 times every hour until 30 days after surgery. |
Standard of care exercise training and supervision
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rate of post operative pulmonary complications within 30 days of surgery
Time Frame: 30 days after surgery
|
Postoperative pulmonary complications (PPCs) are defined as:
|
30 days after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Length of hospital stay
Time Frame: 30 days after surgery
|
30 days after surgery
|
|
Duration of oxygen treatment in hospital
Time Frame: 30 days post-surgery
|
Use of oxygen therapy required while in hospital
|
30 days post-surgery
|
Re-admission to hospital
Time Frame: 30 days
|
Re-admission to hospital due to post operative pulmonary complications
|
30 days
|
Cost effectiveness of spirometry utilization
Time Frame: 30 days after surgery
|
Calculated as an aggregate measure considering length of hospital stay, readmission to hospital and cost of treating complications.
A cost value will be assigned to each group and compared for cost-benefit relationships
|
30 days after surgery
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Wael C Hanna, MDCM MBA FRCSC FCCP, McMaster University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SJHH_Spirometry001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lung Neoplasms
-
UNC Lineberger Comprehensive Cancer CenterSivan Innovation Ltd.CompletedLung Cancer | Neoplasms, Lung | Pulmonary Neoplasms | Neoplasms, Pulmonary | Pulmonary Cancer | Cancer of LungUnited States
-
Baptist Health South FloridaWithdrawnLung Cancer | Lung TumorUnited States
-
Portsmouth Hospitals NHS TrustCompletedLung Cancer | Interstitial Lung DiseaseUnited Kingdom
-
University of UtahRecruitingLung Cancer | Lung Neoplasms/DiagnosisUnited States
-
Point TherapeuticsTerminatedCarcinoma, Non-Small-Cell Lung | Lung Cancer | Neoplasms, Lung | Neoplasms, PulmonaryUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLung Carcinoma | Lung Neoplasm | Malignant Lung NeoplasmUnited States
-
Keimyung University Dongsan Medical CenterCompletedLung Cancer | Lung Diseases, Interstitial
-
Oliver JonasMassachusetts General HospitalCompletedLung Cancer | Lung TumorUnited States
-
C. R. BardCompleted
-
Azienda Sanitaria-Universitaria Integrata di UdineRecruitingLung Diseases | Lung Cancer | Lung Adenocarcinoma | Lung Transplant Rejection | Lung; Node | Lung TBItaly
Clinical Trials on Physiotherapy
-
Hacettepe UniversityCompleted
-
Manchester Metropolitan UniversityCompleted
-
Rigshospitalet, DenmarkThe Association of Danish Physiotherapists Research Fund, Denmark; The Jubilee...CompletedTrismus | Oropharyngeal Cancer | Oral Cavity Carcinoma | Adverse Effect of Radiation TherapyDenmark
-
University of OviedoCompletedParkinson Disease
-
Isra UniversityCompleted
-
University of Nove de JulhoUniversidade Federal do CearáRecruitingEdema | ParesthesiaBrazil
-
Ambreen ChohanBlackpool Victoria HospitalCompletedKnee Osteoarthritis | Exercise | Rehabilitation | Physiotherapy | InterventionUnited Kingdom
-
Assistance Publique - Hôpitaux de ParisMinistry of Health, FranceTerminated
-
Centre Hospitalier Universitaire de Saint EtienneCompleted